Bioaffinity Technologies, Inc. [BIAF]

Source: 

Company Overview

Bioaffinity Technologies, Inc. develop proprietary noninvasive diagnostics to detect early-stage lungcancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificialintelligence (“AI”).